Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE)

Nicolas Vidart d’Egurbide Bagazgoïtia, Helen D. Bailey, Laurent Orsi, Léa Guerrini-Rousseau, Anne Isabelle Bertozzi, Cécile Faure-Conter, Pierre Leblond, Isabelle Pellier, Claire Freycon, François Doz, Stéphanie Puget, Stéphane Ducassou, Brigitte Lacour, Jacqueline Clavel

Research output: Contribution to journalArticle

Abstract

Purpose: Although some specific genetic syndromes such as neurofibromatosis (NF) have been identified as risk factor of childhood brain tumors (CBT), the potential role of inherited susceptibility in CBT has yet to be elucidated. Methods: To further investigate this, we conducted a pooled analysis of two nationwide case–control studies ESCALE and ESTELLE. The mothers of 509 CBT cases and 3,102 controls aged under 15 years who resided in France at diagnosis/interview, frequency-matched by age and gender, responded to a telephone interview conducted by trained interviewers. Pooled odds ratio (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression. Results: CBT was significantly associated with the family history of cancer in relatives (OR 1.2, 95% CI 1.0–1.5). The OR was slightly higher for maternal relatives than for paternal relatives, and when at least two relatives had a history of cancer. CBT was significantly associated with a family history of brain tumor (OR 2.1, 95% CI 1.3–3.7). This association seemed stronger for first-degree relatives (mother, father, and siblings), for whom, by contrast, no association was seen for cancers other than CBT. No specificity by CBT subtypes or by age of the children were found for any of these findings. Conclusion: Our findings support the hypothesis of a familial susceptibility of CBT, not due to being a known NF carrier.

Original languageEnglish
Pages (from-to)1075-1085
Number of pages11
JournalCancer Causes and Control
Volume30
Issue number10
DOIs
Publication statusPublished - 1 Oct 2019

Fingerprint

Brain Neoplasms
Neoplasms
Odds Ratio
Neurofibromatoses
Mothers
Confidence Intervals
Interviews
Fathers
France
Siblings
Logistic Models

Cite this

Vidart d’Egurbide Bagazgoïtia, N., Bailey, H. D., Orsi, L., Guerrini-Rousseau, L., Bertozzi, A. I., Faure-Conter, C., ... Clavel, J. (2019). Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE). Cancer Causes and Control, 30(10), 1075-1085. https://doi.org/10.1007/s10552-019-01214-x
Vidart d’Egurbide Bagazgoïtia, Nicolas ; Bailey, Helen D. ; Orsi, Laurent ; Guerrini-Rousseau, Léa ; Bertozzi, Anne Isabelle ; Faure-Conter, Cécile ; Leblond, Pierre ; Pellier, Isabelle ; Freycon, Claire ; Doz, François ; Puget, Stéphanie ; Ducassou, Stéphane ; Lacour, Brigitte ; Clavel, Jacqueline. / Family history of cancer and the risk of childhood brain tumors : a pooled analysis of the ESCALE and ESTELLE studies (SFCE). In: Cancer Causes and Control. 2019 ; Vol. 30, No. 10. pp. 1075-1085.
@article{d0741db9cccd40daa70263af61e485dd,
title = "Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE)",
abstract = "Purpose: Although some specific genetic syndromes such as neurofibromatosis (NF) have been identified as risk factor of childhood brain tumors (CBT), the potential role of inherited susceptibility in CBT has yet to be elucidated. Methods: To further investigate this, we conducted a pooled analysis of two nationwide case–control studies ESCALE and ESTELLE. The mothers of 509 CBT cases and 3,102 controls aged under 15 years who resided in France at diagnosis/interview, frequency-matched by age and gender, responded to a telephone interview conducted by trained interviewers. Pooled odds ratio (OR) and 95{\%} confidence intervals (95{\%} CI) were estimated using unconditional logistic regression. Results: CBT was significantly associated with the family history of cancer in relatives (OR 1.2, 95{\%} CI 1.0–1.5). The OR was slightly higher for maternal relatives than for paternal relatives, and when at least two relatives had a history of cancer. CBT was significantly associated with a family history of brain tumor (OR 2.1, 95{\%} CI 1.3–3.7). This association seemed stronger for first-degree relatives (mother, father, and siblings), for whom, by contrast, no association was seen for cancers other than CBT. No specificity by CBT subtypes or by age of the children were found for any of these findings. Conclusion: Our findings support the hypothesis of a familial susceptibility of CBT, not due to being a known NF carrier.",
keywords = "Brain tumors, Case–control studies, Childhood cancer, Family history of brain tumor, Family history of cancer, France, Risk factors",
author = "{Vidart d’Egurbide Bagazgo{\"i}tia}, Nicolas and Bailey, {Helen D.} and Laurent Orsi and L{\'e}a Guerrini-Rousseau and Bertozzi, {Anne Isabelle} and C{\'e}cile Faure-Conter and Pierre Leblond and Isabelle Pellier and Claire Freycon and Fran{\cc}ois Doz and St{\'e}phanie Puget and St{\'e}phane Ducassou and Brigitte Lacour and Jacqueline Clavel",
year = "2019",
month = "10",
day = "1",
doi = "10.1007/s10552-019-01214-x",
language = "English",
volume = "30",
pages = "1075--1085",
journal = "Cancer Causes & Control",
issn = "0957-5243",
publisher = "Springer",
number = "10",

}

Vidart d’Egurbide Bagazgoïtia, N, Bailey, HD, Orsi, L, Guerrini-Rousseau, L, Bertozzi, AI, Faure-Conter, C, Leblond, P, Pellier, I, Freycon, C, Doz, F, Puget, S, Ducassou, S, Lacour, B & Clavel, J 2019, 'Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE)' Cancer Causes and Control, vol. 30, no. 10, pp. 1075-1085. https://doi.org/10.1007/s10552-019-01214-x

Family history of cancer and the risk of childhood brain tumors : a pooled analysis of the ESCALE and ESTELLE studies (SFCE). / Vidart d’Egurbide Bagazgoïtia, Nicolas; Bailey, Helen D.; Orsi, Laurent; Guerrini-Rousseau, Léa; Bertozzi, Anne Isabelle; Faure-Conter, Cécile; Leblond, Pierre; Pellier, Isabelle; Freycon, Claire; Doz, François; Puget, Stéphanie; Ducassou, Stéphane; Lacour, Brigitte; Clavel, Jacqueline.

In: Cancer Causes and Control, Vol. 30, No. 10, 01.10.2019, p. 1075-1085.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Family history of cancer and the risk of childhood brain tumors

T2 - a pooled analysis of the ESCALE and ESTELLE studies (SFCE)

AU - Vidart d’Egurbide Bagazgoïtia, Nicolas

AU - Bailey, Helen D.

AU - Orsi, Laurent

AU - Guerrini-Rousseau, Léa

AU - Bertozzi, Anne Isabelle

AU - Faure-Conter, Cécile

AU - Leblond, Pierre

AU - Pellier, Isabelle

AU - Freycon, Claire

AU - Doz, François

AU - Puget, Stéphanie

AU - Ducassou, Stéphane

AU - Lacour, Brigitte

AU - Clavel, Jacqueline

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Purpose: Although some specific genetic syndromes such as neurofibromatosis (NF) have been identified as risk factor of childhood brain tumors (CBT), the potential role of inherited susceptibility in CBT has yet to be elucidated. Methods: To further investigate this, we conducted a pooled analysis of two nationwide case–control studies ESCALE and ESTELLE. The mothers of 509 CBT cases and 3,102 controls aged under 15 years who resided in France at diagnosis/interview, frequency-matched by age and gender, responded to a telephone interview conducted by trained interviewers. Pooled odds ratio (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression. Results: CBT was significantly associated with the family history of cancer in relatives (OR 1.2, 95% CI 1.0–1.5). The OR was slightly higher for maternal relatives than for paternal relatives, and when at least two relatives had a history of cancer. CBT was significantly associated with a family history of brain tumor (OR 2.1, 95% CI 1.3–3.7). This association seemed stronger for first-degree relatives (mother, father, and siblings), for whom, by contrast, no association was seen for cancers other than CBT. No specificity by CBT subtypes or by age of the children were found for any of these findings. Conclusion: Our findings support the hypothesis of a familial susceptibility of CBT, not due to being a known NF carrier.

AB - Purpose: Although some specific genetic syndromes such as neurofibromatosis (NF) have been identified as risk factor of childhood brain tumors (CBT), the potential role of inherited susceptibility in CBT has yet to be elucidated. Methods: To further investigate this, we conducted a pooled analysis of two nationwide case–control studies ESCALE and ESTELLE. The mothers of 509 CBT cases and 3,102 controls aged under 15 years who resided in France at diagnosis/interview, frequency-matched by age and gender, responded to a telephone interview conducted by trained interviewers. Pooled odds ratio (OR) and 95% confidence intervals (95% CI) were estimated using unconditional logistic regression. Results: CBT was significantly associated with the family history of cancer in relatives (OR 1.2, 95% CI 1.0–1.5). The OR was slightly higher for maternal relatives than for paternal relatives, and when at least two relatives had a history of cancer. CBT was significantly associated with a family history of brain tumor (OR 2.1, 95% CI 1.3–3.7). This association seemed stronger for first-degree relatives (mother, father, and siblings), for whom, by contrast, no association was seen for cancers other than CBT. No specificity by CBT subtypes or by age of the children were found for any of these findings. Conclusion: Our findings support the hypothesis of a familial susceptibility of CBT, not due to being a known NF carrier.

KW - Brain tumors

KW - Case–control studies

KW - Childhood cancer

KW - Family history of brain tumor

KW - Family history of cancer

KW - France

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85070257915&partnerID=8YFLogxK

U2 - 10.1007/s10552-019-01214-x

DO - 10.1007/s10552-019-01214-x

M3 - Article

VL - 30

SP - 1075

EP - 1085

JO - Cancer Causes & Control

JF - Cancer Causes & Control

SN - 0957-5243

IS - 10

ER -